Cargando…
Comment on “Replacing the NCCN’s Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?”
Autores principales: | Koh, Wui-Jin, Carlson, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606352/ https://www.ncbi.nlm.nih.gov/pubmed/32588390 http://dx.doi.org/10.1007/s40273-020-00938-y |
Ejemplares similares
-
NCCN Imaging Appropriate Use Criteria Compendium: An Overview
por: Hagaman, Mistie G.
Publicado: (2017) -
The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO
por: Kim, Young Zoon, et al.
Publicado: (2022) -
Impact of the NCCN Biomarkers Compendium on Managed Care Pharmacy
por: Denno, Melissa S., et al.
Publicado: (2013) -
Leaders of ASCO, ASH, ASTRO, and NCCN Embrace Collaboration With Advanced Practitioners
por: Reckling, Susan
Publicado: (2014) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)